Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Double Barreled Antibodies Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Double Barreled Antibodies Drugmarket, defines the market attractiveness level of Double Barreled Antibodies Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Double Barreled Antibodies Drug industry, describes the types of Double Barreled Antibodies Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Double Barreled Antibodies Drug market and the development prospects and opportunities of Double Barreled Antibodies Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Double Barreled Antibodies Drug market in Chapter 13.
By Player:
Merus NV
Glenmark Pharmaceuticals Limited
OncoMed Pharmaceuticals Inc
Amgen Inc
Regeneron Pharmaceuticals Inc
Fresenius SE & Co KGaA
Xencor Inc
Aptevo Therapeutics Inc
Ligand Pharmaceuticals Inc
AbbVie Inc
F Hoffman La Roche Ltd
MacroGenics Inc
By Type:
Removab
BLINCYTO
Others
By End-User:
Lung Cancer
Brain Cancer
Liver Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Double Barreled Antibodies Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Double Barreled Antibodies Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Double Barreled Antibodies Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Double Barreled Antibodies Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Double Barreled Antibodies Drug Market Analysis and Outlook to 2022
-
7.1 Global Double Barreled Antibodies Drug Consumption (2017-2022)
-
7.2 United States Double Barreled Antibodies Drug Consumption (2017-2022)
-
7.3 Europe Double Barreled Antibodies Drug Consumption (2017-2022)
-
7.4 China Double Barreled Antibodies Drug Consumption (2017-2022)
-
7.5 Japan Double Barreled Antibodies Drug Consumption (2017-2022)
-
7.6 India Double Barreled Antibodies Drug Consumption (2017-2022)
-
7.7 South Korea Double Barreled Antibodies Drug Consumption (2017-2022)
8 Region and Country-wise Double Barreled Antibodies Drug Market Analysis and Outlook to 2028
-
8.1 Global Double Barreled Antibodies Drug Consumption Forecast (2022-2028)
-
8.2 United States Double Barreled Antibodies Drug Consumption Forecast (2022-2028)
-
8.3 Europe Double Barreled Antibodies Drug Consumption Forecast (2022-2028)
-
8.4 China Double Barreled Antibodies Drug Consumption Forecast (2022-2028)
-
8.5 Japan Double Barreled Antibodies Drug Consumption Forecast (2022-2028)
-
8.6 India Double Barreled Antibodies Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Double Barreled Antibodies Drug Consumption Forecast (2022-2028)
9 Global Double Barreled Antibodies Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Double Barreled Antibodies Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Removab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global BLINCYTO Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Double Barreled Antibodies Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Brain Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Double Barreled Antibodies Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Double Barreled Antibodies Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Removab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global BLINCYTO Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Double Barreled Antibodies Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Double Barreled Antibodies Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Double Barreled Antibodies Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Double Barreled Antibodies Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Double Barreled Antibodies Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Double Barreled Antibodies Drug Market Competitive Analysis
-
14.1 Merus NV
-
14.1.1 Merus NV Company Details
-
14.1.2 Merus NV Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merus NV Double Barreled Antibodies Drug Product and Service
-
14.2 Glenmark Pharmaceuticals Limited
-
14.2.1 Glenmark Pharmaceuticals Limited Company Details
-
14.2.2 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Product and Service
-
14.3 OncoMed Pharmaceuticals Inc
-
14.3.1 OncoMed Pharmaceuticals Inc Company Details
-
14.3.2 OncoMed Pharmaceuticals Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 OncoMed Pharmaceuticals Inc Double Barreled Antibodies Drug Product and Service
-
14.4 Amgen Inc
-
14.4.1 Amgen Inc Company Details
-
14.4.2 Amgen Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Inc Double Barreled Antibodies Drug Product and Service
-
14.5 Regeneron Pharmaceuticals Inc
-
14.5.1 Regeneron Pharmaceuticals Inc Company Details
-
14.5.2 Regeneron Pharmaceuticals Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Regeneron Pharmaceuticals Inc Double Barreled Antibodies Drug Product and Service
-
14.6 Fresenius SE & Co KGaA
-
14.6.1 Fresenius SE & Co KGaA Company Details
-
14.6.2 Fresenius SE & Co KGaA Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Fresenius SE & Co KGaA Double Barreled Antibodies Drug Product and Service
-
14.7 Xencor Inc
-
14.7.1 Xencor Inc Company Details
-
14.7.2 Xencor Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Xencor Inc Double Barreled Antibodies Drug Product and Service
-
14.8 Aptevo Therapeutics Inc
-
14.8.1 Aptevo Therapeutics Inc Company Details
-
14.8.2 Aptevo Therapeutics Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Aptevo Therapeutics Inc Double Barreled Antibodies Drug Product and Service
-
14.9 Ligand Pharmaceuticals Inc
-
14.9.1 Ligand Pharmaceuticals Inc Company Details
-
14.9.2 Ligand Pharmaceuticals Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Ligand Pharmaceuticals Inc Double Barreled Antibodies Drug Product and Service
-
14.10 AbbVie Inc
-
14.10.1 AbbVie Inc Company Details
-
14.10.2 AbbVie Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AbbVie Inc Double Barreled Antibodies Drug Product and Service
-
14.11 F Hoffman La Roche Ltd
-
14.11.1 F Hoffman La Roche Ltd Company Details
-
14.11.2 F Hoffman La Roche Ltd Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 F Hoffman La Roche Ltd Double Barreled Antibodies Drug Product and Service
-
14.12 MacroGenics Inc
-
14.12.1 MacroGenics Inc Company Details
-
14.12.2 MacroGenics Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 MacroGenics Inc Double Barreled Antibodies Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Double Barreled Antibodies Drug
-
Figure Double Barreled Antibodies Drug Picture
-
Table Global Double Barreled Antibodies Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Double Barreled Antibodies Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Double Barreled Antibodies Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Double Barreled Antibodies Drug Consumption by Country (2017-2022)
-
Figure United States Double Barreled Antibodies Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Double Barreled Antibodies Drug Consumption and Growth Rate (2017-2022)
-
Figure China Double Barreled Antibodies Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Double Barreled Antibodies Drug Consumption and Growth Rate (2017-2022)
-
Figure India Double Barreled Antibodies Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Double Barreled Antibodies Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Double Barreled Antibodies Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Double Barreled Antibodies Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Double Barreled Antibodies Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Double Barreled Antibodies Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Double Barreled Antibodies Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Double Barreled Antibodies Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Double Barreled Antibodies Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Removab Consumption and Growth Rate (2017-2022)
-
Figure Global BLINCYTO Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Brain Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Removab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BLINCYTO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Double Barreled Antibodies Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Double Barreled Antibodies Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Merus NV (Foundation Year, Company Profile and etc.)
-
Table Merus NV Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merus NV Double Barreled Antibodies Drug Product and Service
-
Table Glenmark Pharmaceuticals Limited (Foundation Year, Company Profile and etc.)
-
Table Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Product and Service
-
Table OncoMed Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table OncoMed Pharmaceuticals Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table OncoMed Pharmaceuticals Inc Double Barreled Antibodies Drug Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Double Barreled Antibodies Drug Product and Service
-
Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Inc Double Barreled Antibodies Drug Product and Service
-
Table Fresenius SE & Co KGaA (Foundation Year, Company Profile and etc.)
-
Table Fresenius SE & Co KGaA Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fresenius SE & Co KGaA Double Barreled Antibodies Drug Product and Service
-
Table Xencor Inc (Foundation Year, Company Profile and etc.)
-
Table Xencor Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xencor Inc Double Barreled Antibodies Drug Product and Service
-
Table Aptevo Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Aptevo Therapeutics Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aptevo Therapeutics Inc Double Barreled Antibodies Drug Product and Service
-
Table Ligand Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Ligand Pharmaceuticals Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ligand Pharmaceuticals Inc Double Barreled Antibodies Drug Product and Service
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Double Barreled Antibodies Drug Product and Service
-
Table F Hoffman La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffman La Roche Ltd Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffman La Roche Ltd Double Barreled Antibodies Drug Product and Service
-
Table MacroGenics Inc (Foundation Year, Company Profile and etc.)
-
Table MacroGenics Inc Double Barreled Antibodies Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table MacroGenics Inc Double Barreled Antibodies Drug Product and Service
-
